Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Arch Pharm Res. 2019 Nov 28;43(3):337–349. doi: 10.1007/s12272-019-01192-3

Figure 2: Protective roles of Nrf2 in chronic liver diseases.

Figure 2:

Sequential alterations of steatosis with lipid accumulation, steatohepatitis with inflammation, cirrhosis with fibrosis and liver cancer can be attenuated by Nrf2 activation.